Florida Online MAT Regulations 2026: What Patients Need to Know | Bicycle Health
Florida online MAT regulations 2026: what patients need to know
Telehealth Suboxone treatment for opioid use disorder is legal in Florida in 2026. Florida's telehealth prescribing law restricts telehealth prescribing of Schedule II controlled substances — but buprenorphine (the active ingredient in Suboxone) is classified as Schedule III, which places it outside that restriction. Combined with current federal telehealth rules, Florida patients can access buprenorphine treatment via video visit without a prior in-person evaluation.
This page explains the intersection of Florida state law and federal rules for patients and providers navigating telehealth OUD treatment in Florida.
2026 Florida compliance: quick reference
| Legal requirement | 2026 Florida status | Key detail |
|---|---|---|
| Online initiation without prior in-person visit | Legal | Permitted under DEA Fourth Temporary Extension (through December 31, 2026) and federal buprenorphine telemedicine rule (effective December 31, 2025) |
| In-person visit requirement | Waived under current federal rules | DEA/HHS Fourth Temporary Extension through December 31, 2026 |
| Florida Schedule II telehealth ban (§ 456.47) | Active | Prohibits telehealth prescribing of Schedule II controlled substances with limited exceptions |
| Buprenorphine/Suboxone (Schedule III) | Exempt from Schedule II ban | Florida law permits telehealth prescribing of Schedule III-V controlled substances |
| E-FORCSE PDMP check | Required | Florida prescribers must check E-FORCSE before prescribing controlled substances |
| Electronic prescribing | Required | Florida law requires controlled substance prescriptions to be transmitted electronically |
| Audio-video technology | Required under Florida state law | Florida's telehealth definition requires audio-video technology for standard telehealth; audio-only has specific limitations under Florida law |
| Prescriber requirements | Florida medical license + DEA registration | Provider must be licensed in Florida and hold valid DEA Schedule III prescribing authority |
Key Takeaways
- Online Suboxone treatment for OUD is legal in Florida in 2026. Florida's Schedule II telehealth restriction does not apply to buprenorphine, which is Schedule III under both federal and Florida law.
- Florida's SB 312 (2022), codified in § 456.47, narrowed an earlier blanket restriction. It now prohibits telehealth prescribing only for Schedule II controlled substances, with specific exceptions. Schedule III-V controlled substances, including buprenorphine, can be prescribed via telehealth under Florida law.
- Federal rules further support telehealth access. The DEA/HHS Fourth Temporary Extension (through December 31, 2026) and the permanent Expansion of Buprenorphine Treatment via Telemedicine Encounter rule (effective December 31, 2025) both permit new patient initiation via telehealth without a prior in-person evaluation.
- Florida practitioners must check E-FORCSE, Florida's PDMP, before prescribing. This applies to all controlled substance prescriptions, including buprenorphine, regardless of whether the visit is in-person or telehealth.
- Audio-video is the standard for Florida telehealth. Florida's telehealth law requires audio-video technology for standard telehealth encounters. Patients should expect video visits rather than phone-only calls for evaluations in Florida.
Understanding Florida's telehealth controlled substances law
The Schedule II restriction (SB 312 / § 456.47)
Before 2022, Florida's telehealth law prohibited prescribing any controlled substance via telehealth, with limited exceptions. In 2022, the Florida Legislature passed SB 312, which amended § 456.47, Florida Statutes, to narrow the prohibition. Under current law:
- Schedule II controlled substances may not be prescribed via telehealth in Florida, with four exceptions: treatment of a psychiatric disorder, inpatient hospital treatment, hospice patients, and nursing home residents.
- Schedule III-V controlled substances can be prescribed via telehealth in Florida, within the scope of the practitioner's license and in accordance with other state and federal law.
Buprenorphine is classified as a Schedule III controlled substance by the DEA. This means buprenorphine/naloxone (Suboxone) falls in the Schedule III category and is not subject to the Schedule II telehealth restriction in Florida.
How Florida and federal rules interact
Both Florida law and federal law must be satisfied when prescribing buprenorphine via telehealth to Florida patients.
Florida law permits Schedule III-V telehealth prescribing under § 456.47 and requires:
- The prescriber to hold a valid Florida license
- Compliance with Florida Board of Medicine or applicable board standards of care
- Standard medical evaluation sufficient to diagnose and treat
- E-FORCSE PDMP check before prescribing
- Electronic prescription transmission
Federal law (under the Fourth Temporary Extension and permanent buprenorphine rule) permits:
- Prescribing buprenorphine without prior in-person evaluation
- New patient initiation via telehealth
- Initial buprenorphine supply via telehealth (up to 6 months under the permanent rule; broader flexibility under the temporary extension through 2026)
Both must be satisfied simultaneously. A practitioner prescribing to a Florida patient via telehealth must comply with both Florida's telehealth and prescribing standards and the DEA's telehealth requirements.
E-FORCSE: Florida's prescription drug monitoring program
E-FORCSE (Electronic-Florida Online Reporting of Controlled Substances Evaluated) is Florida's prescription drug monitoring program. Florida law requires prescribers to check E-FORCSE before prescribing a controlled substance.
For buprenorphine prescriptions in Florida:
- The prescriber checks E-FORCSE before the first prescription and at subsequent refills
- The check identifies potential drug interactions, conflicting prescriptions, and patterns that may indicate misuse
- Documentation of the E-FORCSE check date and time is required in the medical record
- This requirement applies equally to telehealth prescriptions and in-person prescriptions
Electronic prescribing in Florida
Florida requires that controlled substance prescriptions be transmitted electronically. Buprenorphine prescriptions in Florida must be e-prescribed to the pharmacy. Paper prescriptions for controlled substances are not permitted in standard circumstances.
Audio-video requirements for Florida telehealth
Florida's telehealth law requires audio-video technology for standard telehealth evaluations. The federal permanent buprenorphine telemedicine rule permits audio-only encounters for buprenorphine OUD treatment at the federal level. However, Florida practitioners must simultaneously comply with Florida law, which requires audio-video for telehealth.
Frequently Asked Questions
Is it legal to get Suboxone online in Florida in 2026?
Yes. Florida's telehealth law restricts telehealth prescribing of Schedule II controlled substances. Buprenorphine (Suboxone) is Schedule III under both federal and Florida law, placing it outside the Schedule II restriction.
Why does Florida restrict Schedule II telehealth but not Schedule III?
Florida's SB 312 (2022) was specifically designed to permit telehealth prescribing of Schedule III-V controlled substances while maintaining stricter rules for Schedule II drugs.
Do I need to use video for my Florida Suboxone visits?
Florida's telehealth law requires audio-video technology for standard telehealth evaluations. You will generally need a smartphone, tablet, or computer with a camera for your visits.
What is E-FORCSE and why does my provider check it?
E-FORCSE is Florida's prescription drug monitoring program. Florida law requires prescribers to check E-FORCSE before prescribing controlled substances.